Rigel Pharmaceuticals

Rigel Pharmaceuticals, Inc. is a biotechnology company headquartered in South San Francisco, California. The company employs 271 individuals and reported $77.5 million in revenue. Rigel Pharmaceuticals focuses on the research, development, and production of innovative small molecule drugs. Their primary target areas are hematologic disorders, cancer, and rare immune diseases. They aim to deliver treatments that measurably enhance the well-being of patients suffering from these conditions. Rigel Pharmaceuticals distinguishes itself through its commitment to developing novel small molecule drugs. This approach allows for targeted therapies with the potential for significant therapeutic benefits. The company's dedication to improving the lives of patients facing serious illnesses drives its research and development efforts. For more information about Rigel Pharmaceuticals and its work, please visit their website at rigel.com.